Personal Finance

Why Accuray Is Soaring Today

Doctor putting his hand on an elderly patient.

What happened

After reporting encouraging fiscal 2019 first-quarter results, shares of Accuray (NASDAQ: ARAY) , a medical device company that makes the CyberKnife Stereotactic Radiosurgery System , were up 35% as of 2:00 p.m. EDT on Wednesday.

So what

Here's a look at the key numbers from the quarter:

  • Revenue increased 5% to $95.8 million. That was a smidge higher than Wall Street was expecting.
  • Net loss was $9.2 million, or $0.11 per share. That was worse than the $0.09 loss that analysts had predicted.

Looking beyond the numbers, management stated that China's Ministry of Health announced Type A and B quotas and licenses and that it is planning on cutting annual operating costs by $15 million to get the company on a path to profitability.

Doctor putting his hand on an elderly patient.

Image source: Getty Images.

In response to these recent news items, the company now expects full-year revenue growth of 3% to 5% and full-year adjusted EBITDA between $23 million and $29 million.

When combined with Accuray's beaten-down share price -- shares had fallen nearly 30% over the last year prior to today's jump -- it is understandable that Accuray's long-suffering bulls are finally having a good day.

Now what

I think that Accuray makes an interesting product that serves a real need, but I have a hard time getting excited about a company that has been a dreadful long-term investment, only promises 5% year-over-year revenue growth, and has to lean on cost-cutting moves to get to profitability. For that reason, my plan is to keep my capital far away from Accuray's stock.

10 stocks we like better than Accuray

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has quadrupled the market.*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Accuray wasn't one of them! That's right -- they think these 10 stocks are even better buys.

Click here to learn about these picks!

*Stock Advisor returns as of August 6, 2018

Brian Feroldi has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ARAY

Other Topics

Stocks

The Motley Fool

Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community. Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription newsletter services, The Motley Fool champions shareholder values and advocates tirelessly for the individual investor. The company's name was taken from Shakespeare, whose wise fools both instructed and amused, and could speak the truth to the king -- without getting their heads lopped off.

Learn More